Vision
Build a repeatable platform for more precise, scalable, and accessible rare disease therapies.
Missions
Personalised Therapeutic Pipeline
SunforestX Therapeutics is a founder-led, early-stage company focused on building a Precision Medicine strategy for rare congenital diseases, combining multi-omics data, AI/ML, and CRO partnerships with translational scientific thinking.
Parkville‑linked positioning
Based in Melbourne, SunforestX leverages the Parkville biomedical precinct— Australia's largest concentration of biomedical research, clinical expertise, and translational infrastructure—for scientific rigor and ecosystem access.
Approach
Bridge data-driven discovery with real-world translational relevance and strategic partnerships.
Context
Operate at the intersection of science, patient need, and sustainable therapeutic innovation.
Located within Melbourne's Parkville biomedical precinct—Australia's largest concentration of biomedical research and clinical expertise.